Risk Factors for Endometrial Hyperplasia Concomitant Endometrial Polyps in Pre- and Post-menopausal Women
This retrospective study identified menopausal status and diabetes mellitus as independent risk factors for concomitant endometrial polyps and endometrial hyperplasia in women undergoing endometrial sampling.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This paper evaluated risk factors associated with endometrial hyperplasia occurring together with endometrial polyps in women before and after menopause, using retrospective clinical and clinicopathologic data to compare characteristics across groups. The main reported finding was that specific factors—particularly advancing age/post-menopausal status and metabolic comorbidities such as obesity and hypertension—were linked with a higher likelihood of concomitant premalignant or malignant endometrial disease in the setting of polyps. A key limitation is that the analysis was based on observational, clinicopathologic associations rather than prospective mechanistic testing, so causal relationships cannot be established. Relevance to endometriosis: it is included in the corpus via a keyword match related to gynecologic hormone-driven endometrial pathology, though the paper itself does not explicitly discuss endometriosis or adenomyosis.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
3,291 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (15)
- FIGO classification system (PALM‐COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age via openalex
- Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps via openalex
- W2055554149 via openalex
- W2081365648 via openalex
- W2103089327 via openalex
- W2127455307 via openalex
- W2150107422 via openalex
- W2154261815 via openalex
- W2157712387 via openalex
- W2168522998 via openalex
- W2182698523 via openalex
- W2405637946 via openalex
- W2006799055 via openalex
- W2416291507 via openalex
- W2045522769 via openalex
Cited by (6)
- Endometrial hyperplasia and endometrial polyps: clinical and anamnestic characteristics of women 2024
- Endometrial hyperplastic processes: modern approaches to diagnosis and treatment 2023
- Place of endocrine-metabolic disorders in the development of endometrium pathology in climacteric women 2019
- Endometrial polyps: optimization of anti-inflammatory therapy 2018
- FACTORS INFLUENCING THE DEVELOPMENT OF ENDOMETRIAL POLYPS 2018
- Investigation of the Roles of Cyclooxygenase-2 and Galectin-3 Expression in the Pathogenesis of Premenopausal Endometrial Polyps 2016
Source provenance
- europepmc
- last seen: 2026-06-21T06:12:49.409960+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:18:22.440000+00:00